Intralesional Treatment of Keloids
ConditionScar, Hypertrophic
Trial statusRecruiting
Trial phasePhase 3
Trial typeInterventional
Biological sexAll
Age18-60
SponsorSohag University
About this trial
Intralesional injection in treatment of keloid
Eligibility criteria
This trial accepts healthy volunteersQualifiers
None
Disqualifiers
pregnancy , lactation Skin disease
Trial design
Design model
Parallel
Treatments tested in this trial
Injection
DrugVitamin D , botox , tramcinolone intralesionally injected in keloid
Treatment groups
45 Participants
are divided into 3 treatment groupsGroup A: Group 1Active comparator 1 intervention
Group B: Group 2Active comparator 1 intervention
Group C: Group 3Active comparator 1 intervention
Trial outcomes
Primary outcomes
1
Posas score
patient and observer parameters will be assessed
Time frame
One session every two weeks total duration 3 monthsSponsors and contacts
Click on the lead sponsor to view all of their trials.
Source ClinicalTrials.gov